Results 71 to 80 of about 3,021 (181)

Characterizing and Identifying the Prevalence of Web-Based Misinformation Relating to Medication for Opioid Use Disorder: Machine Learning Approach

Journal of Medical Internet Research, 2021
BackgroundExpanding access to and use of medication for opioid use disorder (MOUD) is a key component of overdose prevention.
Mai ElSherief, Steven A Sumner, Christopher M Jones, Royal K Law, Akadia Kacha-Ochana, Lyna Shieber, LeShaundra Cordier, Kelly Holton, Munmun De Choudhury   +8 more
doaj   +1 more source

Clinical and Financial Impact of Addiction Medicine Pharmacy Specialist

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 2, February 2026.
ABSTRACT Background Pain management in patients with substance use disorder (SUD) is complex and often under‐addressed in inpatient settings. Clinical pharmacy specialists (CPS) with expertise in pain management and addiction medicine can play a critical role in closing this care gap. To quantify and describe the clinical and financial impact of a Pain
Emily R. Casey, Jacob Radcliff, Tanya J. Uritsky   +2 more
wiley   +1 more source

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

Addiction Science & Clinical Practice, 2023
Background Hospital-based clinicians infrequently initiate medications for opioid use disorder (MOUD) for hospitalized patients. Our objective was to understand hospital-based clinicians’ knowledge, comfort, attitudes, and motivations regarding MOUD ...
Andrea Jakubowski, Sumeet Singh-Tan, Kristine Torres-Lockhart, Shadi Nahvi, Melissa Stein, Aaron D. Fox, Tiffany Lu   +6 more
doaj   +1 more source

Expanding Access to Opioid Use Disorder Treatment: Low‐Threshold Buprenorphine Dispensing via an Interprofessional Mobile Medical Unit in Chicago

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 2, February 2026.
ABSTRACT Background Less than 25% of individuals with opioid use disorder access medication treatment. Lower income and segregated Black and Hispanic communities often have little to no access to services. In 2021, the Drug Enforcement Administration authorized opioid treatment programs to add mobile units to their licensure, extending treatment to ...
Abigail T. Elmes‐Patel, Jennie B. Jarrett, Antonio D. Jimenez, Stockton M. Mayer, Sarah E. Messmer   +4 more
wiley   +1 more source

Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborative.

PLoS ONE
The objective of this study was to estimate the associations of jail-initiated medication for opioid use disorder (MOUD) and patient navigation (PN) with opioid use disorder (OUD) at 6 months post-release.
Joshua D Lee, Keith Goldfeld, Robert P Schwartz, Ryan McDonald, Yifan Xu, Redonna Chandler, Kevin Hallgren, Sharon M Kelly, Shannon Gwinn Mitchell, Anjalee Sharma, David Farabee   +10 more
doaj   +1 more source

Bayesian Clustering Factor Models

Statistics in Medicine, Volume 45, Issue 1-2, January 2026.
ABSTRACT We present a novel framework for concomitant dimension reduction and clustering. This framework is based on a novel class of Bayesian clustering factor models. These models assume a factor model structure where the vectors of common factors follow a mixture of Gaussian distributions.
Hwasoo Shin, Marco A. R. Ferreira, Allison N. Tegge   +2 more
wiley   +1 more source

Association Between Heroin Use and Depression: NHANES 2005–2018

Addiction Biology, Volume 31, Issue 1, January 2026.
Graphical summary illustrating the association between lifetime heroin use and increased odds of clinically significant depression in US adults, with stronger effects observed among younger individuals and current smokers. ABSTRACT Heroin use and major depression are each leading contributors to global disability and premature mortality, yet evidence ...
Bei Li, Zhuojun Yang, Xiaoxiao Zhang, Mei Yang, Hong Qiu, Yulan Ren   +5 more
wiley   +1 more source

Medication for opioid use disorder service delivery in carceral facilities: update and summary report

Health & Justice
The opioid overdose crisis intersects critically with the criminal legal system where individuals with opioid use disorder (are significantly overrepresented.
Justin Berk, Anna-Maria South, Megan Martin, Michael-Evans James, Cameron Miller, Lawrence Haber, Josiah Rich   +6 more
doaj   +1 more source

Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study

Addiction Science & Clinical Practice
Background Opioid-related fatal overdoses are occurring at historically high levels and increasing each year. Accessible social and financial support are imperative to the initiation and success of treatment for Opioid Use Disorder (OUD). Medications for
Emily G. Hichborn, Owen B. Murray, Eilis I. Murphy, Tess E. Gallant, Sarah K. Moore, Bethany M. McLeman, John Saroyan, Anthony Folland, Megan Mitchell, Lisa A. Marsch   +9 more
doaj   +1 more source

The Impact of Prolonged Exposure Therapy on Posttraumatic Stress Disorder Symptom Clusters in Adults Maintained on Medications for Opioid Use Disorder

Clinical Psychology &Psychotherapy, Volume 32, Issue 6, November/December 2025.
ABSTRACT Although prolonged exposure (PE) therapy has shown promise for improving overall posttraumatic stress disorder (PTSD) severity in individuals receiving treatment for opioid use disorder (OUD), its effect on individual PTSD symptom clusters has not been examined in this population.
Jillian A. Giannini, Gary J. Badger, Rebecca Cole, Kelly R. Peck   +3 more
wiley   +1 more source